Gov't reaches 30% of COVID-19 target vaccination with 23.1M individuals fully immunized | Inquirer News

Gov’t reaches 30% of COVID-19 target vaccination with 23.1M individuals fully immunized

/ 01:20 PM October 11, 2021

MANILA, Philippines — Around 23.1 million individuals are now fully vaccinated against COVID-19, Inter-Agency Task Force on Emerging Infectious Diseases (IATF) and Palace spokesperson Harry Roque reported on Monday.

During the Palace briefing, Roque said that of the 77 million target population, 30.06 percent or 23,186,969 people are already fully immunized against the virus, while 26,486,522 individuals or 34.34 percent have received their first dose as of October 10.

Article continues after this advertisement

The country has administered a total of 49,673,491, Roque said.

FEATURED STORIES

In Metro Manila, 7,579,220 individuals or  77.53 percent of the 9.8 million target population  are already fully inoculated.

Of the total 16,500,247 vaccine doses administered in the capital region, 8,921,027 or 91.25 percent were injected with their first dose, the spokesperson noted.

Article continues after this advertisement

Roque urged Filipinos to get vaccinated anew, noting that all vaccine brands that passed the Food and Drug Administration and World Health Organization are safe.

Article continues after this advertisement

RELATED STORIES:

Galvez: Vaccine supply not a problem anymore

Gov’t eases restrictions for arriving, vaccinated travelers

EDV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS:

No tags found for this post.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.